Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 1,065,700	$ 34
Prepaid Expenses	219,171
Total current assets	1,284,871	34
Deferred offering costs		175,378
Cash and Marketable Securities held in Trust Account	151,760,835
Total Assets	153,045,706	175,412
Current liabilities:
Accrued offering costs and expenses	145,651	10,233
Due to related party	131,886
Promissory note – related party		141,451
Total current liabilities	277,537	151,684
Deferred underwriting fee	5,232,500
Warrant liability	10,848,875
Total liabilities	16,358,912	151,684
Commitments
Class A Common Stock subject to possible redemption, 12,974,068 and no shares at redemption value at March 31, 2021 and December 31, 2020, respectively	131,686,791
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 1,975,932 and 0 shares issued and outstanding (excluding 12,974,068 and no shares subject to possible redemption) at March 31, 2021 and December 31, 2020, respectively	198
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,737,500 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	374	374
Additional paid-in capital	2,035,191	24,626
Retained earnings (accumulated deficit)	2,964,240	(1,272)
Total stockholders’ equity	5,000,003	23,728
Total Liabilities and Stockholders’ Equity	$ 153,045,706	$ 175,412